Registered entities
Passage Bio, Inc.
Reg. No. 82-2729751United States
PASSAGE BIO, INC.
Reg. No. 1787297United States
Innovation
3 patent families — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace active. Cited 86 times.
| Year | Filings |
|---|---|
| 2024 | 1 |
| 2025 | 3 |
Social engagement
Social engagement: 15.9K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include Orbimed, Access Biotechnology; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 42% |
| Private equity | 2 | 17% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 4 | 33% |
Recent activity
27 Apr 2026
Event
Association for Frontotemporal Degeneration (AFTD) Education Conference
13 Apr 2026
Event
Webinar on genetics, testing, and inherited risk
3 Mar 2026
Milestone
regulatory